| Sign In to gain access to subscriptions and/or personal tools. |
Barriers to Medication Adherence in Poorly Controlled Diabetes MellitusFrom the Geriatrics Program, School of Pharmacy, and the Department of Medicine, University of Washington (Dr Odegard), and the School of Pharmacy, University of Washington, Seattle, Washington (Dr Gray). Correspondence to Peggy Soule Odegard, PharmD, BCPS, CDE, University of Washington, 1959 NE Pacific Street, Box 357630, Seattle, WA 98195 (podegard{at}u.washington.edu). Purpose The purpose of this study is to characterize the adherence and medication management barriers for adults with poorly controlled type 2 diabetes mellitus (DM) (those with A1c 9% or above) and to identify specific adherence characteristics associated with poor diabetes control. Methods This was a cross-sectional analysis of baseline data from a randomized, controlled diabetes intervention conducted in University of Washington (UW) Medicine Clinics in the greater Seattle, Washington, area.1 The goal of the original study was to evaluate the effect of a pharmacist intervention on improving diabetes control over 12 months. Evaluation measures for medication adherence included self-reported adherence and medication management challenges using the Morisky question format2 and difficulty with taking medications for each diabetes medication based on the Brief Medication Questionnaire.3 Specific adherence characteristics associated with poor diabetes control (A1c >9%) were identified using multivariate regression analysis. Results Seventy-seven subjects (mean A1c, 10.4%; mean duration of DM, 7 years) were studied. The most common adherence challenges included paying for medications (34%), remembering doses (31%), reading prescription labels (21%), and obtaining refills (21%). Taking morethan 2 doses of DM medication daily (β = .78, SE = 0.32, P = .02) and difficulty reading the DM medication prescription label (β = .76, SE = 0.37, P = .04) were significantly associated with higher hemoglobin A1c. Self-reported adherence was not related to A1c control. Conclusions In this study, we identified 2 factors that were associated with poorer A1c control. These findings highlight the importance of identifying potential challenges to medication adherence for those with DM and providing support to minimize or resolve these barriers to control.
The Diabetes Educator, Vol. 34, No. 4,
692-697 (2008) This article has been cited by other articles:
|
||||||||||||||||||||||||||||
